0002114425-26-000003.txt : 20260610 0002114425-26-000003.hdr.sgml : 20260610 20260610161535 ACCESSION NUMBER: 0002114425-26-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260610 DATE AS OF CHANGE: 20260610 EFFECTIVENESS DATE: 20260610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Haku Bio, Inc. CENTRAL INDEX KEY: 0002114425 ORGANIZATION NAME: EIN: 413647221 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-586883 FILM NUMBER: 261079849 BUSINESS ADDRESS: STREET 1: 74 NEWPORT ST CITY: ARLINGTON STATE: MA ZIP: 02476 BUSINESS PHONE: 2066792836 MAIL ADDRESS: STREET 1: 74 NEWPORT STREET CITY: ARLINGTON STATE: MA ZIP: 02476 D/A 1 primary_doc.xml X0708 D/A LIVE 0002114425 Haku Bio, Inc. 74 NEWPORT ST ARLINGTON MA MASSACHUSETTS 02476 2066792836 DELAWARE None None Corporation true 2026 Sandy Mong 74 Newport St. Arlington MA MASSACHUSETTS 02476 Executive Officer Director Bill Lundberg 19 Terrace Ave. Newton MA MASSACHUSETTS 02461 Director Biotechnology No Revenues 06b true 0002114425-26-000002 2026-05-22 false true Simple Agreement for Future Equity (SAFE) false 100000 2710000 1509000 1201000 Total Offering Amount includes up to $2,500,000 of new-money SAFEs plus $210,000 of SAFE issuances in exchange and cancellation of existing convertible promissory notes. false 6 0 0 0 false Haku Bio, Inc. Sandy Mong Sandy Mong, MD CEO 2026-06-10